Nephros, Inc.NEPHNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+5.8%
5Y CAGR+6.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+5.8%/yr
vs +13.9%/yr prior
5Y CAGR
+6.8%/yr
Consistent
Acceleration
-8.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.00M | +17.2% |
| 2024 | $7.68M | -13.9% |
| 2023 | $8.91M | +17.4% |
| 2022 | $7.59M | +5.5% |
| 2021 | $7.20M | +11.3% |
| 2020 | $6.47M | +5.7% |
| 2019 | $6.12M | +35.5% |
| 2018 | $4.52M | +37.0% |
| 2017 | $3.30M | +15.6% |
| 2016 | $2.85M | - |